Get our introductory offer at only
*$0.99/month for first 3 months
$29.90/month for the next 9 months
THE Republic's fledgling pharma ecosystem on Monday got a shot in the arm as biotech startup Aslan Pharmaceuticals announced it has raised US$34 million in Series C funding led by Accuron Technologies, a tech subsidiary of Temasek Holdings.
The proceeds, said Aslan, will...